Suppr超能文献

鉴定新型 L2HGDH 基因突变及更新病理谱。

Identification of novel L2HGDH gene mutations and update of the pathological spectrum.

机构信息

Medical Genetics Center, National Health Institute-INSA, Porto, Portugal.

出版信息

J Hum Genet. 2010 Jan;55(1):55-8. doi: 10.1038/jhg.2009.110. Epub 2009 Nov 13.

Abstract

L-2-hydroxyglutaric aciduria (L-2-HGA, MIM 236792) is a neurometabolic disorder caused by the toxic accumulation of high concentration of L-2-hydroxyglutaric acid in plasma and cerebrospinal fluid. Distinct mutations on the L2HGDH gene have been associated with the clinical and biochemical phenotype. Here we present three novel mutations (Gln197X, Gly211Val and c.540+1 G>A), which increase the present deleterious collection of L2HGDH gene up to 35 mutations that we have compiled in this study. In addition, we used the haplotypic information based on polymorphic markers to demonstrate the common origin of Gly57Arg harboring chromosomes.

摘要

L-2-羟戊二酸尿症(L-2-HGA,MIM 236792)是一种神经代谢紊乱疾病,由血浆和脑脊液中 L-2-羟戊二酸浓度升高引起。L2HGDH 基因突变与临床和生化表型相关。本文报道 3 种新突变(Gln197X、Gly211Val 和 c.540+1 G>A),使 L2HGDH 基因的有害突变总数增加至 35 种,这些突变均来自本研究的病例。此外,我们利用基于多态性标记的单倍型信息证实了携带 Gly57Arg 染色体的共同来源。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验